Paul Hudson (businessman)

Paul Hudson (born 14 October 1967)[2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.[3]

Paul Hudson
Hudson in 2023
Born(1967-10-14)14 October 1967[1]
NationalityBritish
EducationManchester Metropolitan University
TitleCEO, Sanofi
TermSeptember 2019-
PredecessorOlivier Brandicourt
Children3

Early life

Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.[1]

Career

Hudson has been CEO of Sanofi since September 2019.[4][5][6]

Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to president, AstraZeneca United States and Executive Vice President, North America.[6][7][8]

Recognition

Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[1][9]

Personal life

Hudson has three children with his wife Sandra and is an "ardent Manchester United football fan".[1]

References
  1. "Paul Hudson - Sanofi". www.sanofi.com.
  2. "Paul Hudson - Sanofi". www.sanofi.com. Retrieved 29 January 2021.
  3. Willsher, Kim (26 January 2021). "French self-esteem hit after Pasteur Institute abandons Covid vaccine" – via www.theguardian.com.
  4. "Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved". Fortune.
  5. "Sanofi's CEO on a big acquisition, long-term strategy, and vaccines". 17 August 2020.
  6. "Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership". Russell Reynolds Associates.
  7. "AstraZeneca announces changes to Senior Executive Team". Fiercepharma.
  8. "Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis". Novartis. Retrieved 24 April 2023.
  9. "Paul Hudson". Manchester Metropolitan University. Retrieved 24 April 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.